Loading clinical trials...
Loading clinical trials...
A Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study Comparing Dapsone 5% Gel (SEEGPharm SA) to Aczone® and Both Active Treatments Compared to Placebo (Vehicle) in the Treatment of Acne Vulgaris
Conditions
Interventions
Dapsone 5.0% Gel (SEEGPharm)
Placebo
+1 more
Locations
36
United States
Catawba Clinical Research
Encino, California, United States
Catawba Clinical Research
Fullerton, California, United States
Catawba Clinical Research
La Mesa, California, United States
Catawba Clinical Research
Los Angeles, California, United States
Catawba Clinical Research
Los Angeles, California, United States
Catawba Clinical Research
Sherman Oaks, California, United States
Start Date
February 1, 2016
Primary Completion Date
November 1, 2016
Completion Date
December 1, 2016
Last Updated
December 20, 2016
NCT07205107
NCT05891795
NCT06501560
NCT03883269
NCT07469228
NCT07348978
Lead Sponsor
Seegpharm S.A.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions